Telerehabilitation in People With Long COVID (NCT05205460) | Clinical Trial Compass
CompletedNot Applicable
Telerehabilitation in People With Long COVID
Taiwan182 participantsStarted 2021-10-12
Plain-language summary
The aim of our study is to investigate the effectiveness of telerehabilitation in Post-COVID patients.
Who can participate
Age range20 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Individuals who had been diagnosed with COVID-19 positive and whose last PCR test or rapid antigen test was negative with the following criteria:
* aged between 20 to 80 years old
* persistent symptoms at least 4 weeks after recovery from COVID-19 infection, including any of the following symptoms: dyspnea, fatigue, cough, headache, chest tightness, palpitations, loss of smell, anxiety, insomnia, brain fog or joint pain
* able to speak and understand Mandarin
* able to walk including those who need the walking aid
* had mobile phones and could easily access the Internet
Exclusion Criteria:
* a history of chronic obstructive pulmonary disease or other respiratory diseases
* a history of arrhythmia,cancer, end-stage renal disease with dialysis, being diagnosed with mental illness, recent stroke within 6 months
* inability to participate because of comorbid neurological or musculoskeletal conditions that produce moderate to severe physical disability
* need all day oxygen support
What they're measuring
1
Change in Exercise Capacity: Peak Oxygen Uptake (VO2peak) From Baseline to 12 Weeks
Timeframe: Baseline, 12 weeks
2
Change in Exercise Capacity: Workload (Watt) From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
3
Change in Exercise Capacity: Anaerobic Threshold (AT) From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
4
Change in Lung Function: Forced Expiratory Volume 1 (FEV1) From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
5
Change in Lung Function: Forced Vital Capacity (FVC) From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
6
Change in Lung Function: FEV1/FVC % From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
7
Change in Ventilation/ Perfusion Abnormalities (VE/VCO2) From Baseline to 12 Weeks
Timeframe: baseline, 12 weeks
8
Change in Left Ventricular Function: O2 Pulse From Baseline to 12 Weeks